Panagora Asset Management Inc. Acquires 35,093 Shares of Tenet Healthcare Corporation $THC

Panagora Asset Management Inc. lifted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 23.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 186,856 shares of the company’s stock after acquiring an additional 35,093 shares during the quarter. Panagora Asset Management Inc.’s holdings in Tenet Healthcare were worth $37,132,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in THC. NewEdge Advisors LLC lifted its position in Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp lifted its position in Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after buying an additional 1,274 shares during the period. Sivia Capital Partners LLC purchased a new position in Tenet Healthcare during the second quarter valued at $290,000. Quantbot Technologies LP purchased a new position in Tenet Healthcare during the second quarter valued at $65,000. Finally, Amundi lifted its position in Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after buying an additional 26,383 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $179.08 on Tuesday. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The business has a fifty day moving average price of $183.76 and a 200-day moving average price of $199.56. The company has a market capitalization of $15.43 billion, a PE ratio of 9.31, a PEG ratio of 1.44 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same period last year, the company earned $4.36 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts expect that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.97% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on THC shares. Barclays lowered their price objective on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Stephens lowered their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Wells Fargo & Company lowered their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Royal Bank Of Canada reduced their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Finally, KeyCorp reduced their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $244.16.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.